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Abstract
Background: The innate immune responses of neonates differ dramatically from those of adults. Here we examine
the acute inflammatory responses of neonatal and weanling mice infected with pneumonia virus of mice (PVM), a
rodent pathogen (family Paramyxoviridae, genus Pneumovirus) that replicates the sequelae of severe respiratory
syncytial virus infection.
Results: We demonstrate that virus replication proceeds indistinguishably in all age groups (inoculated at 1, 2, 3
and 4 weeks of age), although inflammatory responses vary in extent and character. Some of the biochemical
mediators detected varied minimally with age at inoculation. Most of the mediators evaluated demonstrated
elevated expression over baseline correlating directly with age at the time of virus inoculation. Among the latter
group are CCL2, CCL3, and IFN-g, all cytokines previously associated with PVM-induced inflammatory pathology in
mature mice. Likewise, we detect neutrophil recruitment to lung tissue in all age groups, but recruitment is most
pronounced among the older (3 - 4 week old) mice. Interestingly, all mice exhibit failure to thrive, lagging in
expected weight gain for given age, including the youngest mice that present little overt evidence of
inflammation.
Conclusions: Our findings among the youngest mice may explain in part the phenomenon of atypical or minimally
symptomatic respiratory infections in human neonates, which may be explored further with this infection model.
Background
Nearly all aspects of immune function are distinct in
newborn infants when compared to adults of a given
species. Innate immune responses among mammalian
neonates are typically skewed toward the production of
Th2-type cytokines; the relatively limited capacity for a
Th1 response (TNF, IL-12, IFNg) has been interpreted as
functionally adaptive, serving to protect the developing
fetus and neonate against hyperinflammation and/or
destructive responses to maternal tissues (reviewed in
[1-4]). As such, neonates are particularly vulnerable to
infectious diseases, as they are without adequate defense
against pathogenic bacteria and viruses, and, if infected,
they are potentially predisposed to allergic sequelae [5,6].
As part of our ongoing interest in innate immune
responses to respiratory viral pathogens, we have char-
acterized the pneumonia virus of mice (PVM) infection
model, which replicates the pathogenesis of severe
human respiratory syncytial virus (RSV) infection
responses in inbred strains of mice [7]. PVM replicates
in bronchial epithelial cells, inducing a profile of early
pro-inflammatory mediators, including CCL2, CCL3,
and IFNg, that are associated with respiratory dysfunc-
tion and promote recruitment of inflammatory cells to
lung tissue [8-10]. To date, we have characterized the
biochemical and cellular responses of adult mice (8-12
week old) during infection. In this work, we examine
the innate immune responses to PVM infection in new-
b o r n( 1a n d2w e e ko l d )a n dw e a n l i n g( 3a n d4w e e k
old) mice, as these hosts may more appropriately paral-
lel the human population primarily susceptible to severe
RSV infection [11]. We report our findings on virus
replication as well as biochemical and cellular inflamma-
tory responses to acute PVM infection in this critical
target population, which reveal an intriguing parallel
between neonatal PVM infection and atypical RSV
infection in newborn humans.
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Virus recovery from lung tissue of PVM-infected neonatal
and weanling mice
All mice received a minimal volume inoculum (10 μL)
containing 200 pfu PVM. We found that age at inocula-
tion had no impact on virus recovery [Table 1]. Virus
recovery increased appropriately over time (day 4 vs.
day 7 after inoculation), as one would anticipate for an
actively replicating pathogen, but no significant differ-
ences between groups (age at time of inoculation) were
detected. Virus was undetectable by day 14 among sur-
vivors from each group evaluated (data not shown).
Differential expression of pro-inflammatory mediators
Differential expression (ie...expression in lung tissue of
PVM-infected mice vs. expression in lung tissue of
control mice) of transcripts encoding pro-inflammatory
mediators was examined at day 7 after inoculation.
These differential responses can be divided into two
distinct groups [Table 2]: Group I includes differential
responses that vary minimally (or not at all) with age
at inoculation. These differential responses (including
transcripts encoding CCL1, CCL6, CXCL11, and
CXCL12) not only vary minimally with age at inocula-
tion, the differential responses themselves are minimal,
demonstrating at most 2-fold induction in response to
virus infection. In contrast, Group II includes differen-
tial responses that increase in association with increas-
ing age at inoculation. A good example of a Group II
differential response is interferon-gamma (IFNg), in
which we observe 1.6-fold differential expression
among the mice inoculated at 1 week of age, 1.9-fold
at 2 weeks of age, 18.4-fold at 3 weeks of age, and 26-
fold differential expression among the mice inoculated
at 4 weeks of age. Others included in Group II include
CCL2, CCL3, CXCL1, CXCL9 and CXCL10, which are
all chemokines implicated in inflammatory pathology
in response to PVM infection. These age-dependent
differential responses established by PCR array were
confirmed by detection of immunoreactive protein in
lung tissue [Figure 1].
Leukocyte recruitment and histopathology in PVM-
infected neonatal and weanling mice
Leukocyte recruitment in response to PVM infection
was evaluated as fold-increase over diluent-inoculated
control [Table 3]. We detected prominent recruitment
of neutrophils (CD11c
lo Gr1
+)a n dC D 8
+T cells
(CD3
+CD4
-CD8
+) in mice inoculated at four weeks of
age. As shown in Figure 2, lung tissue of 1 - 2 week old
mice inoculated with PVM display little to no inflamma-
tory pathology (day 7). In contrast, mice inoculated at 3
to 4 weeks of age display significant alveolitis at the day
7 time point, consistent with the biochemical [Table 2]
and cellular [Table 3] inflammatory profiles previously
described.
Weight gain and virus recovery in PVM-infected neonatal
and weanling mice
Normal uninfected neonatal and weanling mice undergo
significant growth over the course of a single week.
Mice infected with PVM at 1, 2 or 3 weeks of age exhi-
bit substantially diminished weight gain over the ensuing
one week period. For example, one week old mice
Table 1 Virus recovery (PVMSH/10
6 GAPDH) from lung
tissue
Virus recovery ( copies PVMSH /1 0
6 GAPDH)
Age at
inoculation
4 days after
inoculation
n 7 days after
inoculation
n
1 week 41 ± 8.8 6 1900 ± 203 12
2 weeks 43 ± 6.7 12 1570 ± 147 21
3 weeks 46 ± 5.9 8 1830 ±218 6
4 weeks 48 ± 9.4 7 1800 ± 132 10
Table 2 Differential inflammatory responses
Age at Inoculation 1 wk 2 wks 3 wks 4 wks
Group I: Differential responses vary minimally with age at
inoculation
CCL1 (TCA-3) 1.2 1.4 2.1 1.6
CCL6 (C10) 1.5 1.7 0.9 2.0
CXCL11 (I-Tac) 1.1 0.6 1.0 0.9
CXCL12 1.0 1.5 0.9 0.7
Group II: Differential responses increase with age at inoculation
CCL2 (MCP-1)
a 0.6 0.1 1.5 1.9
CCL3 (MIP-1a)
a 1.9 2.2 9.8 9.2
CCL4 (MIP-1b) 1.3 1.5 9.8 11.3
CCL5 (RANTES) 1.8 2.9 3.5 4.9
CCL7 (MCP-3) 1.1 1.2 5.8 7.5
CCL8 (MCP-2) 2.2 4.4 1.4 12.1
CCL9 (MIP-1g) 1.3 1.5 1.4 4.9
CCL11 (eotaxin) 1.9 1.1 2.3 4.3
CCL12 (MCP-5) 1.0 1.9 0.9 3.7
CCL17 (TARC) 1.2 0.9 1.0 14.9
CCL19 (MIP-3b) 2.1 0.9 1.3 29.9
CCL24 (eotaxin 2) 0.8 1.7 0.9 2.1
CXCL-1 (KC)
a 1.4 1.4 0.7 6.5
CXCL9 (MIG)
a 2.5 1.6 78.8 84.4
CXCL10 (IP-10)
a 2.2 2.1 36.8 45.3
CXCL13 1.3 1.8 1.3 7.0
TNF 1.7 1.4 4.6 2.2
IFNg
a 1.6 1.9 18.4 26.0
Expression of proinflammatory mediators detected by PCR array analysis of
RNA from lung tissue of infected mice vs. RNA from lung tissue from age-
matched uninfected controls; t = day 7 after inoculation. Ages of mice at time
of inoculation are as indicated;
acorresponding immunoreactive protein shown
in Figure 1.
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Page 2 of 8Figure 1 Proinflammatory mediators expressed in lung tissue in response to PVM infection. Detection of immunoreactive (A) CCL3 (B)
CXCL10 (C) CXCL9 (D) CXCL1 (E) CCL2 and (F) IFNg in response to PVM infection in mice at 1 week (white bars), 2 weeks (light gray bars), 3
weeks (dark gray bars) or 4 weeks old (black bars) at time of virus inoculation. Detection of immunoreactive protein is shown at days 0, 4, and 7
after inoculation for all mice. Statistical significance, *p < 0.05 vs. mediator levels of mice from younger age groups (inoculated at 1 or 2 weeks
old), evaluated at day 7; n = 4 - 6 mice per group.
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Page 3 of 8infected with PVM have gained an average of 32% body
weight by 7 days post-inoculation, at the peak of virus
recovery; meanwhile, their uninfected counterparts have
increased their body weight by 60% (p < 0.05; [Figure 3])
By 4 weeks of age, growth rate of uninfected mice has
diminished; accordingly, PVM infection in these mice
did not have as substantial an impact on body weight.
By day 10 after inoculation, weight gain resumed in all
age groups (data not shown). However, the crucial point
is that all PVM-infected mice exhibit failure to thrive,
even the youngest mice that experience minimal bio-
chemical and cellular inflammation.
Discussion
In this work, we show that acute inflammatory
responses to PVM infection vary substantially with age
at inoculation, which are significantly more robust
among the older mice in our study; the responses of the
Table 3 Leukocyte recruitment in response to PVM
infection
Age at inoculation
Cell type - Ag profile 1
week
2
weeks
3
weeks
4
weeks
PMN CD11c
lo Gr1
hi 1.5 1.9 1.8 3.2
MØ CD11c
+ CD11b
- 1.0 1.8 1.8 1.8
mDC CD11c
+ CD11b
+ 1.0 1.4 1.6 1.7
pDC CD11c
lo Gr1
+ B220
+
1.1 1.9 2.1 1.7
CD4
+ T
cell
CD3
+ CD4
+ CD8
- 1.0 1.2 1.4 1.4
CD8
+ T
cell
CD3
+ CD4
- CD8
+ 1.0 1.1 2.3 2.4
B cells CD3
+ CD19
+ 0.9 1.9 1.4 1.5
Data shown represent fold-increase over number of cells detected in age-
matched mice inoculated with diluent control; n = 4 mice per condition, t =
day 7 after inoculation. PMN, neutrophils; MØ, macrophages; mDC, myeloid
dendritic cells; pDC, plasmacytoid dendritic cells.
Figure 2 Histopathologic analysis. Hematoxylin and eosin-(H&E) stained lung tissue from mice inoculated with PVM at (A) 1 week (B) 2 weeks
(C) 3 weeks or (D) 4 weeks of age. Lung tissue sample was taken at day 7 after inoculation; original magnification, 10×.
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those described previously in our earlier studies of adult
(6 - 8 week old) mice [7-10]. Although several studies
have documented Th2-skewing and secondary responses
to virus pathogens in newborn and neonatal mice
[12-14], there are few systematic evaluations of primary
inflammatory responses to these virus pathogens during
normal neonatal development. As such, it is interesting
to compare our findings with those from a recent study
of bovine RSV pathogenesis, in which the authors com-
pared the responses of experimentally-inoculated neona-
tal (1 day old) and 6 week old immunologically-naïve
calves to acute infection [15]. The two groups display
similar peak virus recoveries, but, likewise similar to our
results, the neonatal calves experienced limited TNF-
alpha expression and neutrophil recruitment in response
to acute virus infection.
Our finding that PVM-associated inflammatory
responses in the youngest mice are dramatically different
from those of older juvenile mice provides substantial
insight into a long-standing clinical observations regard-
ing neonatal hRSV infection in humans. Specifically,
infants who develop hRSV bronchiolitis beyond the neo-
natal period develop the telltale symptom complex of
nasal congestion, tachypnea, and diffuse expiratory
wheezing, much of which is thought to be caused by
virus-induced inflammatory responses. In contrast,
human newborns infected with RSV often do not develop
a wheezing illness, but instead present with nonspecific
signs of illness such as temperature instability, poor
feeding, periodic breathing, or apnea. The atypical nature
of RSV infection in these young newborns was first
described by Hall and colleagues [16]. In this cohort,
nearly half of the RSV-infected newborns had lethargy, a
third presented with poor feeding, and 15% had apnea
episodes; cough, fever and wheezing were absent. Among
the interpretations provided, Hall and colleagues sug-
gested that the atypical symptom complex may result
from the inability to mount a robust inflammatory
response. These observations were mirrored by those
of Wilson and colleagues [17] who described a similar
symptom complex in a neonatal intensive care unit out-
break of RSV infection, and our recent study of asympto-
matic respiratory virus infection among neonatal
intensive care unit patients [manuscript in review].
Given the blunted inflammatory responses observed in
neonates, it is important to consider what other factors
might be promoting respiratory or even systemic illness
in this uniquely susceptible target population. Among
humans, one might consider the role of maternal antibo-
dies against the RSV pathogen, which have been explored
as promoting protection and in vaccination strategies
[18-22]. Interestingly, as the mice used in this study were
born to immunologically naïve mothers, the differences
in inflammatory pathology observed cannot be attributed
to the presence or absence of maternally-derived anti-
PVM antibodies. However, there is a substantial literature
on the extra-pulmonary manifestations of RSV infection
[reviewed in [23,24]]. For example, RSV infection in
human infants is clearly associated with an increased
Figure 3 Acute PVM infection results diminished growth. Mice were inoculated with 10 μL/200 pfu PVM J3666 (filled symbols) or phosphate
buffered-saline control (open symbols) at 1, 2, 3, or 4 weeks of age as shown. Weight was evaluated at day 0 and at day 7; percent (%) change
was measured as [(weight day 7 - weight day 0) × 100/weight day 0.]. Net weight loss was observed in some PVM-infected weanling mice (7 of
44); statistical significance, *p < 0.05, **p < 0.005; n = 19 - 31 mice per group.
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Page 5 of 8incidence of cardiac arrhythmias [25]. RSV infection also
correlates with an increased incidence of central apnea,
without any specific association to the ensuing inflamma-
tory response [26]; the link between RSV and apnea has
been noted with respect to the link between virus infec-
tion and sudden infant death syndrome [27]. Further-
more, a recent study of post-mortem lung tissue by
Welliver and colleagues [28] points to a potential role for
epithelial cell apoptosis; Bem and colleagues [29] have
noted that there are elevated levels of biologically-active
soluble TNF-related apoptosis-inducing ligand (sTRAIL)
in BAL fluids from infants mechanically-ventilated due to
severe RSV infection.
Any one or all of these factors combined may pro-
mote weight loss, systemic symptoms, and even death in
the absence of inflammatory pathology in the lung.
Conclusions
PVM infection presents in an atypical fashion in neona-
tal mice. Although virus replication proceeds indistin-
guishably when compared to older mice, chemokine
production is minimal in lung tissue of neonatal mice
and recruitment of proinflammatory leukocytes is like-
wise diminished. Interestingly, despite diminished
inflammatory responses, neonatal mice exhibit failure to
thrive, with a markedly diminished weight gain for age
similar to virus-infected newborn humans. A systematic
study of early responses to PVM infection in newborn
mice will provide further insights into the ontogeny of
the innate immune response and ultimately a better
understanding of the mechanisms involved in neonatal
RSV infection.
Methods
Mice
Specific pathogen-free C57Black/6 breeding pairs were
purchased from Taconic Laboratories (Rockville, MD).
These mice remained seronegative for pneumonia virus
of mice (PVM) antigens while in use as breeders. For
experiments in which newborn mice were inoculated
with PVM prior to weaning (hereafter described as neo-
natal mice), the adult breeder pair was retired, and not
used to generate offspring for additional experiments.
Each experiment included at least four mice per data-
point, and all experiments were performed three or four
times. Clinical symptoms and weights were recorded
daily.
Virus
Virus stocks of mouse-passaged PVM strain J3666
stored in liquid nitrogen were diluted 1:1000 in PBS to
a final concentration of 200 plaque forming units (pfu
[30])/10 μL. Mice were inoculated intra-nasally with
10 μL PVM in PBS or 10 μLo fP B Sa l o n ea n dw e r e
evaluated immediately following inoculation (day 0) or
on days 4 or 7 thereafter. Virus recovery from lung tis-
sue was determined by a quantitative RT-PCR assay tar-
geting the PVM small hydrophobic (SH) gene as
previously described [31], and expressed as copies PVM
SH gene per copies cellular GAPDH (PVMSH/10
6
GAPDH).
Preparation of single cell suspensions from lung tissue
and flow cytometry
Mice were sacrificed by cervical dislocation under iso-
flurane anesthesia. Lungs were perfused in situ by inject-
ing the right ventricle with 0.01 M EDTA in PBS to
flush out circulating blood cells. Perfused lungs were
removed by dissection and placed into 2 ml RPMI 1640
with 5% fetal bovine serum (FBS). The lungs were
teased and cut into pieces and then digested with 3 mL
RPMI with 5% FBS, 20 μg/mL DNAse I and 2 mg/mL
collagenase D (digestion media). The lungs were then
washed in additional digestion media and incubated at
37°C with rocking for 90 minutes. Halfway through the
digestion time, 2 mL fresh digestion medium was added.
After an additional 90 minutes, digests were placed on
ice, and EDTA was added to a final concentration of 10
mM. After 5 minutes, the preparations were strained
through a 60 micron cell strainer over a conical tube.
The sample was collected via centrifugation, and the
remaining red blood cells lysed with 5 mL ammonium
chloride sodium bicarbonate (ACK) buffer. Following a
5 minute lysis, the cells were washed twice in Wuerz-
burg buffer (0.3% BSA in PBS containing 0.005 M
EDTA and DNase I), then twice in Hanks balanced salt
solution. Isolated lung cells were counted and stained
for flow cytometry using the following antibodies and
dilutions (all from Becton Dickinson (BD) Biosciences
Rutherford, NJ) CD11c-APC at 1:100, CD19-APC at
1:200, CD11b-APCCy7 at 1:400, Gr1-APCCy7 at 1:200,
CD4-APCCy7 at 1:100, CD80-PE at 1:100, Mac3-PE at
1:100, CD11b-PE at 1:200, CD8-PE at 1:50, NK1.1-PE at
1:50, CD45-PECy7 at 1:1600, MHCII-FITC at 1:100,
CD103-FITC at 1:100, B220-FITC at 1:100, and CD3e-
FITC at 1:50, all after blocking with anti-FcgIII/II
receptor antibody. Data were collected on an LSRII flow
cytometer (BD Biosciences); live cells were analyzed by
gating on forward-side scatter. Data were acquired using
FACSDIVA software (BD Biosciences) and populations
analyzed with FlowJo version 8.7.3 (Tree Star, Inc.
Ashland, OR).
Detection of transcripts encoding proinflammatory
mediators
One μg of total RNA extracted from lungs of PVM- or
diluent control- inoculated mice (day 7, n = 4 mice per
point) was used to perform RT
2 Profiler(tm) PCR Arrays,
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platform (PCR Superarray, SA Biosciences Corporation,
Frederick MD) as per manufacturer’s instructions. First
strand cDNA was used for real-time PCR detection of
transcripts encoding cytokines, chemokines and related
inflammatory mediators and 5 housekeeping genes; con-
trols for genomic DNA contamination, reverse transcrip-
tion, and PCR amplification were included. All threshold
values equal to or greater than 35 were considered as
negative. The average value of all housekeeping genes
was calculated to establish baseline expression, and ΔCt
was determined by subtracting the mean Ct for the
housekeeping genes from the Ct for each transcript of
interest. The ΔΔCt was calculated for each gene across
two groups [ΔCt (experimental group) - ΔCt (control
group)]. Fold change was then determined by calculating
2
(-ΔΔCt).
Detection of immunoreactive pro-inflammatory mediators
in response to PVM infection
Perfused lungs removed from PVM- and diluent-control
inoculated mice were blade-homogenized into 1 mL
PBS. Cytokines were detected using commercial ELISA
kits (R&D Systems, Minneapolis, MN). Protein concen-
tration in each sample was determined by BCA assay.
Histopathology
On day 7, lungs of sacrificed mice were inflated trans-
tracheally using 250 μL 10% phosphate-buffered
formalin. The lungs and heart were removed and fixed
overnight in 10% phosphate-buffered formalin at 4°C.
Samples were paraffin-embedded, sectioned, and stained
with hematoxylin and eosin (Histoserv, Inc., German-
town, MD).
Statistical analysis
Data were analyzed by ANOVAw i t hp o s t - h o ca n a l y s i s
or Student’s t-test as appropriate. Outlier datapoints
were assessed by Grubb’s test.
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